Tau neuronal and glial pathologies drive the clinical presentation of Alzheimer's disease
and related human tauopathies. There is a growing body of evidence indicating that …

Zebrafish (Danio rerio) have become a powerful tool in neuroscience research due to their
genetic tractability, molecular/physiological conservation, small body size, ease of …

Green synthesis processes are regarded as safer alternative to usual physical, chemical and
microbial methods due to their cost effectiveness, environmental friendly nature and easy …

Transdermal drug delivery (TDD) systems with feedback control have attracted extensive
research and clinical interest owing to their unique advantages of convenience, self …

This study focuses on the green synthesis of silver and gold nanoparticles using the marine
algae extract, Sargassum horneri, as well as the degradation of organic dyes using …

Methylene blue (MB), the first synthetic drug, has a 120-year-long history of diverse
applications, both in medical treatments and as a staining reagent. In recent years there was …

Methylene Blue (MB), following its introduction to biology in the 19th century by Ehrlich, has
found uses in various areas of medicine and biology. At present, MB is the first line of …

CONCLUSIONS Methylene Blue was till now known mainly as a dye but is now entering into
the field of cardiac surgery and critical care as a very important therapeutic agent with …

Current approved drug treatments for Alzheimer disease (AD) include cholinesterase
inhibitors (donepezil, rivastigmine, galantamine) and the NMDA receptor antagonist …

Many hypotheses have been raised regarding the pathophysiology of Alzheimer's disease
(AD). Because amyloid beta peptide (Aβ) deposition in senile plaques appears as a late …